Glaucoma warning
Use caution if you have glaucoma or increased eye pressure.
Leaflet RYALTRIS 25mcg / 600mcg / dose nasal spray, solution
- Product code:
- W67951003
- Quantity:
- 1
- Indicated for:
- allergic rhinitis
- Route of administration:
- nasal
- Substance:
- olopatadine + mometasone (antihistamine + glucocorticoid)
- ATC
- R01AD59 — Respiratory system | Decongestants and other nasal preparations for topical use | Corticosteroids
Precautions:
Hyperglycemia
This medicine may increase blood sugar.
Immunosuppression / infection risk
This medicine may increase the risk of infections.
Breastfeeding warning
Use during breastfeeding only on medical advice.
Pregnancy warning
Use during pregnancy only on medical advice.
The combination of olopatadine and mometasone is used in the treatment of seasonal or perennial allergic rhinitis. Olopatadine is an antihistamine that reduces allergic symptoms, while mometasone is a corticosteroid that reduces nasal inflammation.
The medication is administered as a nasal spray, as directed by a doctor, usually once or twice daily. It is important for patients to follow the recommended dosage and avoid long-term use without medical supervision.
Patients should be aware of potential side effects, such as nasal irritation, dryness, or nosebleeds. It is important to inform the doctor of any unusual symptoms.
Common side effects include nasal irritation, dryness, and nosebleeds. In rare cases, severe reactions such as nasal infections or allergic reactions may occur. Patients should be informed of these risks before use.
The medication is administered as a nasal spray, as directed by a doctor, usually once or twice daily. It is important for patients to follow the recommended dosage and avoid long-term use without medical supervision.
Patients should be aware of potential side effects, such as nasal irritation, dryness, or nosebleeds. It is important to inform the doctor of any unusual symptoms.
Common side effects include nasal irritation, dryness, and nosebleeds. In rare cases, severe reactions such as nasal infections or allergic reactions may occur. Patients should be informed of these risks before use.
General data about RYALTRIS 25mcg / 600mcg / dose
- Substance:
- olopatadine + mometasone
- Date of latest medicines list:
- 01-06-2026
- Product code:
- W67951003
- Concentration:
- 25mcg / 600mcg / dose
- Pharmaceutical form:
- nasal spray, solution
- Quantity:
- 1
- Product type:
- Original
- Price:
- 71.79 RON
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.